Delivery of Personalized Care for Locally Advanced Rectal Cancer: Incorporating Pathological, Molecular Genetic, and Immunological Biomarkers Into the Multimodal Paradigm
Approximately Wire Harness one-third of all newly diagnosed colorectal cancer (CRC) is composed of rectal cancer, with the incidence rising in younger patients.The principal neoadjuvant treatments consist of neoadjuvant short-course radiotherapy and long-course chemoradiation.Locally advanced rectal cancer (LARC) is particularly challenging to mana